Monthly Archives: January 2013

The Sims 3 Generations - The Young, The Old and The Genome
The Sims 3 Generation OST The Young, The Old and The Genome Create-a-Sim Steve Jablonsky

By: Georgegiles123

Go here to read the rest:
The Sims 3 Generations - The Young, The Old and The Genome - Video

2013 Health Headlines - DNA and The human Genome
forurocstars.com Biggest health stories for 2013 on ABC. Dr. Nancy talks about how DNA testing is going to hit BIG in 2013 as we understand more about your own bodies- we will be healthier!!! Foru has a product line custom made for your DNA. Learn more forurocstars.com

By: forurocstars

Original post:
2013 Health Headlines - DNA and The human Genome - Video

UW Genome Sciences - Distinguished Faculty Interview Series: Walt Fangman
MKRaghuraman interviews Walt Fangman, 1 October 2012 UWGS_gsdfis_2012.10.01_Fangman-293m.mp4

By: UWGenomeSciences

Read the original post:
UW Genome Sciences - Distinguished Faculty Interview Series: Walt Fangman - Video

Parasitic DNA in the human genome?
Is the human genome full of parasites? This might seem like a ridicules question but some researchers suggest that it is. The human genome project revealed that a large number of transposable elements. These DNA segments copy themselves and move around the genome. Some scientists claim they serve no function and have dismissed them as parasitic DNA. Some evolutionary scientists claim that similarities with chimps in these supposedly useless bits prove evolution. But new research shows they have functions. One study revealed that transposable elements activate during embryo development in mice, to control gene expression. Another study revealed they activate in gene dense regions to control gene expression. They are not spread randomly throughout the genome as previously thought. So DNA isn #39;t full of parasites at all, but rather many sophisticated ways to control gene expression. Related Articles: Junk DNA Evolutionary Discards or God #39;s tools? (creation.com Large Scale Function for ERVs (endogenous retroviruses) (creation.com No Joy for Junkies (creation.com Related Products: How Evolution Hurts Science DVD (creation.com

By: CMIcreationstation

More here:
Parasitic DNA in the human genome? - Video

EMERYVILLE, Calif.--(BUSINESS WIRE)--

Omicia, Inc., a privately held company offering integrated solutions for interpreting human genome sequences, today announced the appointment of Mike Aicher as Chief Executive Officer and member of the companys Board of Directors.

We are thrilled to bring Mike on board as we launch commercial operations for our new human genome interpretation platform, said Omicia co-founder Dr. Martin Reese. Mikes three decades of experience in the development and commercialization of advanced genetic testing services are a perfect fit for Omicia as we enter the genomic medicine market, where entrepreneurship and clinical expertise are needed to build successful businesses.

Prior to joining Omicia, Mr. Aicher was CEO of National Genetics Institute (NGI), a company he co-founded in 1991 and later became a wholly owned subsidiary of Laboratory Corporation of America (LabCorp). Most recently, Mr. Aicher led LabCorps Western Division and was previously responsible for the companys Esoteric Business Units, which generated more than $1 billion in annual revenue. Prior to NGI, Mr. Aicher served in a number of executive leadership roles at Central Diagnostics Laboratory. He is certified by the University of California at Berkeley as a Global Biotechnology Executive and is a recipient of Ernst & Youngs Entrepreneur of the Year award for emerging technologies. Mr. Aicher received a B.S. in Business Administration from the University of Redlands and an M.B.A. in economics from Columbus University.

For genomic testing to reach its full potential, we must simplify the analysis of complex sequence data so that we can integrate this information with other routine tests to help diagnose disease and guide treatment decisions, said Mr. Aicher. Martin and the outstanding Omicia team have built a truly ground-breaking genome interpretation platform with the highest levels of scientific credibility. I look forward to leading Omicia as we enter the commercial market to bring researchers and clinicians better tools for translating genomic data into medically actionable information.

Omicia Chairman Dr. John Stuelpnagel added, We are delighted that Mike has joined our team and look forward to supporting him as he builds out Omicias commercial operations. Mikes deep operational expertise, coupled with the world-class genomics and software engineering team assembled by Martin will help Omicia make genome analysis a more routine part of health care delivery.

For more information about Omicia, please visit http://www.omicia.com.

About Omicia, Inc.

Based in the San Francisco Bay Area, Omicia develops scalable and fully integrated informatics systems specifically designed to interpret human genome sequences for research and clinical applications. Omicia's mission is to help research scientists, clinicians and patients better understand the most relevant information from personal genome sequences and their potential medical consequences. Omicia is funded with private investments and a series of Small Business Innovation Research (SBIR) grants from the National Institutes of Health. For more information, please visit http://www.omicia.com.

See more here:
Genome Interpretation Company Omicia Appoints Mike Aicher as CEO